#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary angioedema with C1 esterase inhibitor deficiency Raynaud's phenomenon Haemophilia A without inhibitors Short stature homeobox gene mutation Antithrombin III deficiency Adrenogenital syndrome Squamous cell carcinoma of the oral cavity Spinal muscular atrophy Waldenstrom's macroglobulinaemia refractory X-linked lymphoproliferative syndrome Testicular leiomyosarcoma Precursor T-lymphoblastic lymphoma/leukaemia recurrent Parkinson's disease Hereditary haemorrhagic telangiectasia Type IIa hyperlipidaemia More trials…

    Learn about Rare Diseases

    Chordoma – Trials in Disease Waldenstrom’s macroglobulinaemia refractory Medulloblastoma – Trials in Disease Glomerulonephritis membranoproliferative – Diagnostics Acquired haemophilia – Life with Disease Chronic granulomatous disease – Life with Disease Acute respiratory distress syndrome – Diagnostics Richter’s syndrome Richter’s syndrome – Diagnostics Factor VIII deficiency – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Verapamil Ondansetron Fasudil Hydrochloride Calcium Chloride Dihydrate CAMOSTAT MESILATE Bay 2927088 Amantadine Hydrochloride MEGESTROL ACETATE Tolu Balsam Iopromide Omx-0407 Mitoxantrone Hydrochloride Sxr1096 Msv/As USNOFLAST Lbl-007 Mifamurtide Tegafur Ads-015 Glasdegib More therapies…

    Learn about Your Condition

    Open angle glaucoma Haemodialysis Urethral valves Milk allergy Polymyalgia rheumatica Cataract White matter lesion Primary hyperaldosteronism Nephrotic syndrome Pharyngeal cancer stage I Hyperchylomicronaemia Pemphigus Hypertrophic scar Arteriospasm coronary Bacterial infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Obesity

  • Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Maridebart Cafraglutide
    Belgium Czechia Denmark Finland Germany Italy +2

  • Study on the Effectiveness of Survodutide for Weight Loss in Patients with Type 2 Diabetes and Obesity

    Not recruiting

    3 1
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Belgium Czechia Denmark Finland Germany Greece +5

  • Study on the Effectiveness of Survodutide for Weight Loss in Adults with Obesity Without Diabetes

    Not recruiting

    3 1
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Belgium Finland Germany The Netherlands Poland Sweden

  • Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study of Retatrutide for Patients with Obesity, Overweight, and Chronic Low Back Pain

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Back pain
    • Obesity
    • Overweight
    Investigated Drugs:
    • Ly3437943 Sodium
    Poland

  • Study on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight

    Not recruiting

    3 1
    Belgium Bulgaria Denmark Finland France Germany +4
Previous Page
1 … 10 11 12 13 14 … 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!